Defense One

And just like that, the Navy’s frigate program is back on—sort of

SIMI VALLEY, California.—The White House has greenlit a plan to design and build a frigate domestically as part of its proposed “Golden Fleet,” Navy Secretary John Phelan announced at the Reagan ...
C&EN

Methylene Group Insertion into a C–N Bond: The Mechanism for the Biosynthesis of Dehydrofosmidomycin by a Nonheme Iron Oxygenase

Manchester Institute of Biotechnology, The University of Manchester, 131 Princess Street, Manchester M1 7DN, United Kingdom Department of Chemistry, The University of Manchester, Oxford Road, ...
precisionmedicineonline

Intellia Cuts AATD Gene Insertion Program, 27 Percent of Workforce in Strategic Reorganization

NEW YORK – Intellia Therapeutics on Thursday announced a strategic reorganization, including discontinuing development of an early-stage gene-editing candidate and layoffs. The Cambridge, ...
C&EN

Rh(III)-Catalyzed Regioselective Alkyne Insertion in the Context of C–H Activation and Lactonization Reactions: Synthesis of Fused 1,2-Oxaphospholenes

Institute of Next Generation Matter Transformation, College of Material Sciences Engineering, Huaqiao University, Xiamen, Fujian 361021, China Key Laboratory of Molecule Synthesis and Function ...
TechRepublic

The 5 Best Online C Programming Courses

Learning to program in C on an online platform can provide structured learning and a certification to show along with your resume. Looking into learning C, one of the most popular programming ...
thetechedvocate.org

How to Get Color in C Program

Since technology is not going anywhere and does more good than harm, adapting is the best course of action. That is where The Tech Edvocate comes in. We plan to cover the PreK-12 and Higher Education ...
Business Wire

Precision BioSciences Announces Approval of First Clinical Trial Application of ARCUS Gene Insertion Program by Partner iECURE

DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies ...